Principal Financial Group
TXG icon

Principal Financial Group’s 10x Genomics TXG Stock Holding History

Principal Financial Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.92M Buy
258,693
+31,863
+14% +$835K ﹤0.01% 1411
2026
Q1 		$4.82M Sell
226,830
-22,177
-9% -$443K ﹤0.01% 1641
2025
Q4 		$4.06M Buy
249,007
+86,805
+54% +$1.31M ﹤0.01% 1681
2025
Q3 		$1.9M Buy
+162,202
New +$2.11M ﹤0.01% 1824
2024
Q3 		– Sell
-12,624
Closed -$246K – 2407
2024
Q2 		$246K Sell
12,624
-7,403
-37% -$194K ﹤0.01% 2098
2024
Q1 		$752K Sell
20,027
-1,441
-7% -$63.3K ﹤0.01% 1910
2023
Q4 		$1.2M Sell
21,468
-2,273
-10% -$98.9K ﹤0.01% 1818
2023
Q3 		$979K Buy
23,741
+948
+4% +$49.3K ﹤0.01% 1846
2023
Q2 		$1.27M Sell
22,793
-490
-2% -$26.5K ﹤0.01% 1814
2023
Q1 		$1.3M Sell
23,283
-2,407
-9% -$112K ﹤0.01% 1819
2022
Q4 		$936K Buy
25,690
+4,211
+20% +$138K ﹤0.01% 1868
2022
Q3 		$612K Sell
21,479
-1,249
-5% -$47.6K ﹤0.01% 1917
2022
Q2 		$1.03M Buy
22,728
+2,103
+10% +$109K ﹤0.01% 1914
2022
Q1 		$1.57M Sell
20,625
-1,225
-6% -$107K ﹤0.01% 1902
2021
Q4 		$3.25M Sell
21,850
-5,981
-21% -$916K ﹤0.01% 1783
2021
Q3 		$4.05M Sell
27,831
-3,148
-10% -$540K ﹤0.01% 1745
2021
Q2 		$6.07M Buy
30,979
+7,731
+33% +$1.4M ﹤0.01% 1649
2021
Q1 		$4.21M Buy
23,248
+1,320
+6% +$228K ﹤0.01% 1712
2020
Q4 		$3.1M Buy
21,928
+10,231
+87% +$1.48M ﹤0.01% 1699
2020
Q3 		$1.46M Sell
11,697
-1,058
-8% -$111K ﹤0.01% 1800
2020
Q2 		$1.14M Buy
+12,755
New +$993K ﹤0.01% 1809

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Principal Financial Group's TXG Position: Q2 2026 in Review

Principal Financial Group increased its 10x Genomics (TXG) stake by 14% in Q2 2026, buying an estimated $835K and bringing the position to 258,693 shares worth $9.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

Principal Financial Group first reported a position in TXG in Q2 2020 and has held it in 21 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Principal Financial Group held 258,693 shares of 10x Genomics worth $9.92M as of Q2 2026.
  • Principal Financial Group bought 31,863 10x Genomics shares in Q2 2026, an estimated $835K.
  • 10x Genomics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1411 holding.
  • Principal Financial Group first reported a position in 10x Genomics in Q2 2020 and has held it in 21 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.